Suppr超能文献

化疗后小儿髓母细胞瘤并发脊髓硬膜外脂肪增多症:一例报告并文献复习

Spinal epidural lipomatosis in pediatric medulloblastoma following chemotherapy, a case report and review of the literature.

作者信息

Keswa Mandisa L, Tran Hung N, Esfahani Darian R

机构信息

Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, CA, USA.

Department of Pediatric Hematology-Oncology, Kaiser Permanente Los Angeles Medical Center, Los Angeles, CA, USA.

出版信息

Childs Nerv Syst. 2025 Feb 1;41(1):99. doi: 10.1007/s00381-025-06757-w.

Abstract

PURPOSE

Spinal epidural lipomatosis (SEL) is a relatively rare condition characterized by overgrowth of adipose tissue in the extradural space of the spinal canal. Compression of neural structures can lead to radiculopathy, loss of sensation and motor function, and urinary retention. Known causes of SEL include exogenous steroid use and obesity.

METHODS

We describe the unique case of idiopathic SEL in a 1-year-old male, the youngest reported to date, diagnosed with medulloblastoma and treated with chemotherapy and autologous stem cell rescue (AuSCR). We then perform a systemic review of the literature of this rare diagnosis, explore potential causes, and review management.

RESULTS

The patient was non-obese and received a cumulative dose of only 60 mg dexamethasone (150 mg/m), far below pediatric cancer patients with SEL documented in the literature. The acute presentation of lipomatosis following chemotherapy and AuSCR, associated with transient elevated triglycerides (234 mg/dL), suggests this as a possible cause.

CONCLUSION

This case illustrates the development and resolution of SEL in a non-obese pediatric cancer patient with limited steroid use. While further study is needed to identify the etiology of SEL, this diagnosis should be evaluated for when reviewing spine imaging following chemotherapy or autologous stem cell rescue.

摘要

目的

脊髓硬膜外脂肪增多症(SEL)是一种相对罕见的病症,其特征是椎管硬膜外间隙脂肪组织过度生长。神经结构受压可导致神经根病、感觉和运动功能丧失以及尿潴留。已知的SEL病因包括外源性类固醇使用和肥胖。

方法

我们描述了一名1岁男性特发性SEL的独特病例,这是迄今为止报道的最年轻病例,该患者被诊断为髓母细胞瘤并接受了化疗和自体干细胞救援(AuSCR)治疗。然后,我们对关于这一罕见诊断的文献进行了系统综述,探讨了潜在病因,并回顾了治疗方法。

结果

该患者不肥胖,仅接受了累积剂量为60毫克地塞米松(150毫克/平方米)的治疗,远低于文献中记录的患有SEL的儿科癌症患者。化疗和AuSCR后脂肪增多症的急性表现,与甘油三酯短暂升高(234毫克/分升)相关,提示这可能是一个病因。

结论

本病例说明了一名使用类固醇有限的非肥胖儿科癌症患者SEL的发生和消退情况。虽然需要进一步研究以确定SEL的病因,但在化疗或自体干细胞救援后复查脊柱影像时应考虑这一诊断。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验